Page 4 - நிறுவனம் ஆஃப் குழந்தை ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed. For the study, published in Brain Communications, clinicians evaluated the use of K.Vita®, (also known as Betashot), an oral liquid dietary supplement developed by UCL in collaboration with Royal Holloway, University of London, and Vitaflo International Ltd. The ketogenic diet (KD) consists of high-fat, low-carbohydrate and adequate protein consumption and mimics the fasting state, altering the metabolism to use body fat as the primary fuel source. This switch from carbohydrates to fat for body fuel is known as ketosis.

Natasha schoelerQueen square institute of neurologyBrain communicationsNational hospital for neurologyResearch dietitianUniversity of londonChalfont centre for epilepsyVitaflo international ltdInstitute of child healthRoyal hollowayVitaflo internationalProfessor matthew walkerSquare instituteProfessor walkerNational hospitalOrmond street institute